Portfolio news 0

Oxa

Dubai Future Foundation and Oxa launch joint venture, transforming Dubai into global hub for autonomous logistics

Iksuda Therapeutics Ltd

Iksuda receives US FDA IND clearance for IKS04

Accelercomm Ltd

AccelerComm powers Eclipse Space’s 5G physical layer for sovereign satellite constellations

Mach42 completes £7m funding round, led by IP Group with investment from BGF and Foresight Group

Mission Therapeutics Limited

Mission Therapeutics strikes deal worth up to $292m for Dimerix Ltd to develop Acute Kidney Injury asset MTX652

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Half year trading update and notice of results

Istesso Ltd

Istesso initiates Phase 2 clinical trial of leramistat in sarcopenia

Hysata

Hysata celebrates five years of growth and diversity with its first electrolyser order

Mantle8

France doubles down on natural hydrogen as Mantle8 secures exclusive Pyrenees permit

Pfizer obesity royalty interest

Robust Phase 2b efficacy and favorable tolerability support monthly dosing for Pfizer’s GLP-1 RA Berobenatide